Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • acidcoated
    Junior Member
    • Jun 2014
    • 3

    #1

    Confusion about single end vs paired end read output on Illumina HiSeq

    Hello,

    I think I'm confused about read output for Illumina's HiSeq. I think I'm not understanding why it is possible to get 150M single end reads in a run, but you can get 300M pairs (is this double the data)? So what is the maximum number of TOTAL reads you can get (either on rapid-run or high-output).
    I'm trying to understand multiplexing better. Because multiplexing is based on how many reads you desire, you determine how many libraries you can load in a single lane based on the max output (~140-150M reads) of a lane.
    So say I want 20M single end reads, I can load 6 libraries safely with some buffer room and reach 20M reads per library. But if you want paired end reads, how does this work say if I want 20M pairs (40M total) per library; can I still load 6 libraries and reach that output? Is this purely based on maximum data that can be produced or on the chemistry of the SBS reagents in single end vs paired end mode?
    Any resources are greatly appreciated. Thanks!
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Unique clusters is what you need to consider.

    If you sequence only one end then you get 150M reads but if you sequence the other then you get 300M reads. Each unique cluster can generate n x 2 number of reads. Illumina tends to quote number of paired end reads in their specifications (so that corresponds to half the number of unique clusters being sequenced).

    In example above you don't change the loading concentration but just sequence the other end of the fragment to get a pair of reads for each cluster.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    17 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...